The PE ratio for Organon stock stands at 5.24 as of Sep 6, 2024. This is calculated based on the TTM EPS of $3.91 and the stock price of $20.49 per share. The current PE ratio is nearly the same compared to the last four quarters average.
Over the last four years, the average PE ratio of Organon has been 6.14. The current 5.24 price-to-earnings ratio is 15% less than the historical average. Analyzing the last four years, OGN's PE ratio reached its highest point in the Mar 2023 quarter at 8.03, with a price of $23.52 and an EPS of $2.93. The Dec 2023 quarter saw the lowest point at 3.6, with a price of $14.42 and an EPS of $4.01.
Maximum annual increase: 35.55% in 2022
Maximum annual decrease: -53.49% in 2023
Year | PE ratio | Change |
---|---|---|
2023 | 3.6 | -53.49% |
2022 | 7.74 | 35.55% |
2021 | 5.71 | N/A |
2020 | N/A | N/A |
2019 | N/A | N/A |
2018 | N/A | N/A |
The current PE ratio of OGN is under its 3-year average.
Stock name | PE ratio | Market cap |
---|---|---|
OGN Organon & Co | 5.24 | $5.28B |
OPTN OptiNose Inc | N/A | $143.49M |
OPK Opko Health Inc | N/A | $1.09B |
ORGO Organogenesis Holdings Inc | N/A | $327.46M |
The price to earnings ratio for OGN stock as of Sep 6, 2024, stands at 5.24.
The 3-year average PE ratio for OGN stock is 6.29.
The highest quarterly PE ratio in the last four years has been 8.03 and it was in the Mar 2023 quarter.
The current PE ratio of OGN is 15% lower than the 4-year historical average.
A company with a lower PE ratio may indicate that the market has lower growth expectations for the company's future earnings.
The P/E ratio is calculated by dividing the latest price of a stock by its trailing twelve months EPS. As of today (Sep 6, 2024), Organon's share price is $20.49. The company's earnings per share for the trailing twelve months (TTM) ending Jun 2024 is $3.91. Therefore, Organon's price to earnings ratio for today is 5.24. PE RATIO(5.24) = STOCK PRICE($20.49) / TTM EPS($3.91)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified. Data from and Sharadar.